Ingagen M 0.2mg Injection
Marketer
Inga Laboratories Pvt Ltd
Salt Composition
Methylergometrine (0.2mg)
Overview Ingagen M 0.2mg Injection
Postpartum or post-abortion uterine bleeding is managed with Ingagen M 0.2mg Injection. This medication acts on uterine smooth muscle, enhancing its contractility (tone, frequency, and strength of contractions), thereby minimizing blood loss. Administration is strictly by a physician, intravenously or intramuscularly, within a hospital setting; self-injection is prohibited. Dosage and frequency are tailored to individual needs and determined by your doctor, who will adjust treatment to optimize symptom control. Headache, hypertension, and seizures are potential side effects; report any concerning symptoms immediately. Mitigation strategies may be available. Alcohol consumption is generally discouraged during treatment. Prior to commencing treatment, disclose any history of heart disease or hypertension, and provide a complete list of all other medications being taken, as interactions can compromise efficacy or alter the drug's action.
Uses of Ingagen M 0.2mg Injection
Hemorrhage postpartum
Major Benefits of Ingagen M 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ingagen M 0.2mg Injection:
- High blood pressure
- Headache
- Seizure
How to use Ingagen M 0.2mg Injection:
Administering this medication will be done by your physician or their designated nurse; self-medication is strictly prohibited.
How Ingagen M 0.2mg Injection works:
Ingagen M 0.2mg Injection, an ergot alkaloid derivative, induces prolonged uterine smooth muscle contractions. This vascular compression effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ingagen M 0.2mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyUNSAFE
Administering Ingagen M 0.2mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, given that research in animals and pregnant women indicates considerable harm to the fetus.
Breast feedingCAUTION
The administration of Ingagen M 0.2mg Injection to breastfeeding mothers requires careful consideration. It is recommended to discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingCONSULT YOUR DOCTOR
The effect of Ingagen M 0.2mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Ingagen M 0.2mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ingagen M 0.2mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Ingagen M 0.2mg Injection :
NA
Facts to Know About Ingagen M 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Category | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Actions | Drugs that induce uterine contractions and/or abortion |
3,018 People bought this recently